Press Releases
Investor Resources
Press Releases
Press Release
Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business AdvisorDecember 18, 2019
Press Release
Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to its Board of DirectorsDecember 3, 2019
Press Release
Cardiol Therapeutics comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement AgencyNovember 25, 2019
Press Release
Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx™100October 1, 2019
Press Release
Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12thSeptember 5, 2019
Press Release
Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth ConferenceJuly 29, 2019